638 related articles for article (PubMed ID: 26381230)
21. Gut microbiome and amyotrophic lateral sclerosis: A systematic review of current evidence.
Sun J; Huang T; Debelius JW; Fang F
J Intern Med; 2021 Oct; 290(4):758-788. PubMed ID: 34080741
[TBL] [Abstract][Full Text] [Related]
22. The impact of gut microbiota on brain and behaviour: implications for psychiatry.
Dinan TG; Cryan JF
Curr Opin Clin Nutr Metab Care; 2015 Nov; 18(6):552-8. PubMed ID: 26372511
[TBL] [Abstract][Full Text] [Related]
23. From the Gut to the Brain: Is Microbiota a New Paradigm in Parkinson's Disease Treatment?
Vilela C; Araújo B; Soares-Guedes C; Caridade-Silva R; Martins-Macedo J; Teixeira C; Gomes ED; Prudêncio C; Vieira M; Teixeira FG
Cells; 2024 Apr; 13(9):. PubMed ID: 38727306
[TBL] [Abstract][Full Text] [Related]
24. Gut microbiota: Implications in Parkinson's disease.
Parashar A; Udayabanu M
Parkinsonism Relat Disord; 2017 May; 38():1-7. PubMed ID: 28202372
[TBL] [Abstract][Full Text] [Related]
25. Therapeutics for neurodegenerative diseases by targeting the gut microbiome: from bench to bedside.
Ma YY; Li X; Yu JT; Wang YJ
Transl Neurodegener; 2024 Feb; 13(1):12. PubMed ID: 38414054
[TBL] [Abstract][Full Text] [Related]
26. The alteration of gut microbiome and metabolism in amyotrophic lateral sclerosis patients.
Zeng Q; Shen J; Chen K; Zhou J; Liao Q; Lu K; Yuan J; Bi F
Sci Rep; 2020 Aug; 10(1):12998. PubMed ID: 32747678
[TBL] [Abstract][Full Text] [Related]
27. An update on long-term in vivo and in vitro studies designed to identify a virus as the cause of amyotrophic lateral sclerosis, parkinsonism dementia, and Parkinson's disease.
Gibbs CJ; Gajdusek DC
Adv Neurol; 1982; 36():343-53. PubMed ID: 6817614
[No Abstract] [Full Text] [Related]
28. What Are the Key Gut Microbiota Involved in Neurological Diseases? A Systematic Review.
Bonnechère B; Amin N; van Duijn C
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430144
[TBL] [Abstract][Full Text] [Related]
29. The gut microbiome in Parkinson's disease: A culprit or a bystander?
Keshavarzian A; Engen P; Bonvegna S; Cilia R
Prog Brain Res; 2020; 252():357-450. PubMed ID: 32247371
[TBL] [Abstract][Full Text] [Related]
30. Gut microbiota are related to Parkinson's disease and clinical phenotype.
Scheperjans F; Aho V; Pereira PA; Koskinen K; Paulin L; Pekkonen E; Haapaniemi E; Kaakkola S; Eerola-Rautio J; Pohja M; Kinnunen E; Murros K; Auvinen P
Mov Disord; 2015 Mar; 30(3):350-8. PubMed ID: 25476529
[TBL] [Abstract][Full Text] [Related]
31. Unhealthy gut, unhealthy brain: The role of the intestinal microbiota in neurodegenerative diseases.
Spielman LJ; Gibson DL; Klegeris A
Neurochem Int; 2018 Nov; 120():149-163. PubMed ID: 30114473
[TBL] [Abstract][Full Text] [Related]
32. Brain-Gut-Microbiota Axis in Amyotrophic Lateral Sclerosis: A Historical Overview and Future Directions.
Chen S; Cai X; Lao L; Wang Y; Su H; Sun H
Aging Dis; 2024 Feb; 15(1):74-95. PubMed ID: 37307822
[TBL] [Abstract][Full Text] [Related]
33. Parkinson's Disease and the Gut: Symptoms, Nutrition, and Microbiota.
Yemula N; Dietrich C; Dostal V; Hornberger M
J Parkinsons Dis; 2021; 11(4):1491-1505. PubMed ID: 34250955
[TBL] [Abstract][Full Text] [Related]
34. Potential Role of Gut Microbiota in ALS Pathogenesis and Possible Novel Therapeutic Strategies.
Mazzini L; Mogna L; De Marchi F; Amoruso A; Pane M; Aloisio I; Cionci NB; Gaggìa F; Lucenti A; Bersano E; Cantello R; Di Gioia D; Mogna G
J Clin Gastroenterol; 2018; 52 Suppl 1, Proceedings from the 9th Probiotics, Prebiotics and New Foods, Nutraceuticals and Botanicals for Nutrition & Human and Microbiota Health Meeting, held in Rome, Italy from September 10 to 12, 2017():S68-S70. PubMed ID: 29782468
[TBL] [Abstract][Full Text] [Related]
35. Gut-Modulating Agents and Amyotrophic Lateral Sclerosis: Current Evidence and Future Perspectives.
Noor Eddin A; Alfuwais M; Noor Eddin R; Alkattan K; Yaqinuddin A
Nutrients; 2024 Feb; 16(5):. PubMed ID: 38474719
[TBL] [Abstract][Full Text] [Related]
36. Healthy Gut, Healthy Brain: The Gut Microbiome in Neurodegenerative Disorders.
Chandra S; Alam MT; Dey J; Sasidharan BCP; Ray U; Srivastava AK; Gandhi S; Tripathi PP
Curr Top Med Chem; 2020; 20(13):1142-1153. PubMed ID: 32282304
[TBL] [Abstract][Full Text] [Related]
37. Altered gut microbiota and intestinal permeability in Parkinson's disease: Pathological highlight to management.
Sharma S; Awasthi A; Singh S
Neurosci Lett; 2019 Nov; 712():134516. PubMed ID: 31560998
[TBL] [Abstract][Full Text] [Related]
38. The Gut and Nonmotor Symptoms in Parkinson's Disease.
Klingelhoefer L; Reichmann H
Int Rev Neurobiol; 2017; 134():787-809. PubMed ID: 28805583
[TBL] [Abstract][Full Text] [Related]
39. [The role of the gut microbiota in Parkinson's disease].
Verugina NI; Levin OS; Lyashenko EA
Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(10. Vyp. 2):86-91. PubMed ID: 34870920
[TBL] [Abstract][Full Text] [Related]
40. Gut microbiota differences between healthy older adults and individuals with Parkinson's disease: A systematic review.
Nuzum ND; Loughman A; Szymlek-Gay EA; Hendy A; Teo WP; Macpherson H
Neurosci Biobehav Rev; 2020 May; 112():227-241. PubMed ID: 32032654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
